{"id":54839,"date":"2026-02-24T05:49:58","date_gmt":"2026-02-24T05:49:58","guid":{"rendered":"https:\/\/www.globalresearch.co.kr\/insight\/acute-lymphoblastic-leukemia-therapeutics-market-mordor\/"},"modified":"2026-09-25T01:43:27","modified_gmt":"2026-09-24T16:43:27","slug":"acute-lymphoblastic-leukemia-therapeutics-market-mordor","status":"publish","type":"post","link":"https:\/\/www.globalresearch.co.kr\/insight\/acute-lymphoblastic-leukemia-therapeutics-market-mordor\/","title":{"rendered":"\uc138\uacc4\uc758 \uae09\uc131 \ub9bc\ud504\ubaa8\uad6c \ubc31\ud608\ubcd1 \uce58\ub8cc\uc81c \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc810\uc720\uc728 \ubd84\uc11d &#8211; \uc131\uc7a5 \ucd94\uc138 \ubc0f \uc804\ub9dd (2026-2031\ub144)"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/acute-lymphoblastic-leukemia-therapeutics-market-1749055372861-major-players.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/acute-lymphoblastic-leukemia-therapeutics-market-size-image-1770802900441.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-0\">1. \uc11c\ub860<\/p>\n<ul>\n<li class=\"toc-level-2\">1.1 \uc5f0\uad6c \uac00\uc815 \ubc0f \uc2dc\uc7a5 \uc815\uc758<\/li>\n<li class=\"toc-level-2\">1.2 \uc5f0\uad6c \ubc94\uc704<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-1\">2. \uc5f0\uad6c \ubc29\ubc95\ub860<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-2\">3. \uc694\uc57d<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-3\">4. \uc2dc\uc7a5 \ud604\ud669<\/p>\n<ul>\n<li class=\"toc-level-2\">4.1 \uc2dc\uc7a5 \uac1c\uc694<\/li>\n<li class=\"toc-level-2\">4.2 \uc2dc\uc7a5 \ub3d9\uc778\n<ul>\n<li class=\"toc-level-3\">4.2.1 \uc18c\uc544\uc554 \uce58\ub8cc \ud504\ub85c\uadf8\ub7a8\uacfc \ud568\uaed8 \uae09\uc131 \ub9bc\ud504\uad6c\uc131 \ubc31\ud608\ubcd1\uc758 \ub192\uc740 \ubd80\ub2f4<\/li>\n<li class=\"toc-level-3\">4.2.2 \uc784\uc0c1 \uc2dc\ud5d8 \ubc0f \ud30c\uc774\ud504\ub77c\uc778 \uc57d\ubb3c \ud655\ub300\uc640 \ud568\uaed8 \uc99d\uac00\ud558\ub294 \uc5f0\uad6c \uac1c\ubc1c \uc774\ub2c8\uc154\ud2f0\ube0c<\/li>\n<li class=\"toc-level-3\">4.2.3 \uc2e0\uc18d \uc2b9\uc778\uacfc \uac19\uc740 \uc720\ub9ac\ud55c \uaddc\uc81c \uc774\ub2c8\uc154\ud2f0\ube0c<\/li>\n<li class=\"toc-level-3\">4.2.4 \uc561\uccb4 \uc0dd\uac80 \ubc0f \ubbf8\uc138 \uc794\uc874 \uc9c8\ud658 \uac80\uc0ac\uc758 \uc801\uc6a9 \uc99d\uac00<\/li>\n<li class=\"toc-level-3\">4.2.5 \ud45c\uc801 \uce58\ub8cc\ubc95\uc758 \ubc1c\uc804<\/li>\n<li class=\"toc-level-3\">4.2.6 \uc0c1\uc5c5\uc801 \ud655\uc7a5\uc131 \ubc0f \ud658\uc790 \uc801\uaca9\uc131\uc744 \uac00\uc18d\ud654\ud558\ub294 \uae30\uc131\ud488 \ub3d9\uc885 CAR-T \ud50c\ub7ab\ud3fc\uc73c\ub85c\uc758 \uc804\ud658<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.3 \uc2dc\uc7a5 \uc81c\uc57d\n<ul>\n<li class=\"toc-level-3\">4.3.1 \ub192\uc740 \uce58\ub8cc \ube44\uc6a9 \ubc0f \uc0c1\ud658 \ubb38\uc81c<\/li>\n<li class=\"toc-level-3\">4.3.2 \uc7ac\ubc1c \ubc0f \uce58\ub8cc \uc800\ud56d\uc131\uacfc \uad00\ub828\ub41c \ubd80\uc791\uc6a9 \uc704\ud5d8<\/li>\n<li class=\"toc-level-3\">4.3.3 \uc758\ub8cc \uc811\uadfc\uc131\uc758 \ubd88\uade0\ud615 \ubc0f \uc2e0\uaddc \uce58\ub8cc\ubc95\uc758 \ubd88\ud655\uc2e4\ud55c \uc7a5\uae30 \uacb0\uacfc<\/li>\n<li class=\"toc-level-3\">4.3.4 \uc81c\ud55c\ub41c \ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130 \uc81c\uc870 \ub2a5\ub825\uc73c\ub85c \uc778\ud55c \ucca8\ub2e8 \uce58\ub8cc\uc81c\uc758 \uc0dd\uc0b0 \uc9c0\uc5f0 \ubc0f \uacf5\uae09 \uc81c\uc57d<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.4 \uac00\uce58 \/ \uacf5\uae09\ub9dd \ubd84\uc11d<\/li>\n<li class=\"toc-level-2\">4.5 \uaddc\uc81c \ubc0f \uae30\uc220 \uc804\ub9dd<\/li>\n<li class=\"toc-level-2\">4.6 \ud3ec\ud130\uc758 5\uac00\uc9c0 \uacbd\uc7c1 \uc694\uc778 \ubd84\uc11d\n<ul>\n<li class=\"toc-level-3\">4.6.1 \uc2e0\uaddc \uc9c4\uc785\uc790\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.6.2 \uad6c\ub9e4\uc790\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.6.3 \uacf5\uae09\uc790\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.6.4 \ub300\uccb4\uc7ac\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.6.5 \uacbd\uc7c1 \uac15\ub3c4<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-4\">5. \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc608\uce21 (\uac00\uce58 &#8211; USD)<\/p>\n<ul>\n<li class=\"toc-level-2\">5.1 \uc138\ud3ec \uc720\ud615\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.1.1 B\uc138\ud3ec \uc804\uad6c\uccb4 ALL<\/li>\n<li class=\"toc-level-3\">5.1.2 T\uc138\ud3ec ALL<\/li>\n<li class=\"toc-level-3\">5.1.3 \ud544\ub77c\ub378\ud53c\uc544 \uc5fc\uc0c9\uccb4 (Ph+ \/ Ph\u2013)<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.2 \uce58\ub8cc\ubc95\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.2.1 \ud654\ud559\uc694\ubc95\n<ul>\n<li class=\"toc-level-4\">5.2.1.1 Hyper-CVAD<\/li>\n<li class=\"toc-level-4\">5.2.1.2 CALGB 8811<\/li>\n<li class=\"toc-level-4\">5.2.1.3 \ub9c1\ucee4<\/li>\n<li class=\"toc-level-4\">5.2.1.4 \ub274\ud074\ub808\uc624\uc0ac\uc774\ub4dc \uc5b5\uc81c\uc81c<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-3\">5.2.2 \ud45c\uc801 \uce58\ub8cc<\/li>\n<li class=\"toc-level-3\">5.2.3 \ubc29\uc0ac\uc120 \uce58\ub8cc<\/li>\n<li class=\"toc-level-3\">5.2.4 \uc904\uae30\uc138\ud3ec \uc774\uc2dd\n<ul>\n<li class=\"toc-level-4\">5.2.4.1 \uc790\uac00<\/li>\n<li class=\"toc-level-4\">5.2.4.2 \ub3d9\uc885<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-3\">5.2.5 CAR-T \/ \uc138\ud3ec \uce58\ub8cc\n<ul>\n<li class=\"toc-level-4\">5.2.5.1 CD19<\/li>\n<li class=\"toc-level-4\">5.2.5.2 \ucc28\uc138\ub300 (\uc774\uc911 \ud56d\uc6d0, \ub3d9\uc885)<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.3 \uc5f0\ub839\ub300\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.3.1 \uc18c\uc544 (0\u201318\uc138)<\/li>\n<li class=\"toc-level-3\">5.3.2 \uc131\uc778 (19\u201364\uc138)<\/li>\n<li class=\"toc-level-3\">5.3.3 \ub178\uc778 (\u226565\uc138)<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.4 \uce58\ub8cc \ub77c\uc778\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.4.1 1\ucc28 \uce58\ub8cc<\/li>\n<li class=\"toc-level-3\">5.4.2 2\ucc28 \uce58\ub8cc<\/li>\n<li class=\"toc-level-3\">5.4.3 \uc7ac\ubc1c\uc131 \/ \ubd88\uc751\uc131<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.5 \ud22c\uc5ec \uacbd\ub85c\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.5.1 \uc815\ub9e5<\/li>\n<li class=\"toc-level-3\">5.5.2 \uacbd\uad6c<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.6 \uc9c0\uc5ed\n<ul>\n<li class=\"toc-level-3\">5.6.1 \ubd81\ubbf8\n<ul>\n<li class=\"toc-level-4\">5.6.1.1 \ubbf8\uad6d<\/li>\n<li class=\"toc-level-4\">5.6.1.2 \uce90\ub098\ub2e4<\/li>\n<li class=\"toc-level-4\">5.6.1.3 \uba55\uc2dc\ucf54<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-3\">5.6.2 \uc720\ub7fd\n<ul>\n<li class=\"toc-level-4\">5.6.2.1 \ub3c5\uc77c<\/li>\n<li class=\"toc-level-4\">5.6.2.2 \uc601\uad6d<\/li>\n<li class=\"toc-level-4\">5.6.2.3 \ud504\ub791\uc2a4<\/li>\n<li class=\"toc-level-4\">5.6.2.4 \uc774\ud0c8\ub9ac\uc544<\/li>\n<li class=\"toc-level-4\">5.6.2.5 \uc2a4\ud398\uc778<\/li>\n<li class=\"toc-level-4\">5.6.2.6 \uae30\ud0c0 \uc720\ub7fd<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-3\">5.6.3 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591\n<ul>\n<li class=\"toc-level-4\">5.6.3.1 \uc911\uad6d<\/li>\n<li class=\"toc-level-4\">5.6.3.2 \uc77c\ubcf8<\/li>\n<li class=\"toc-level-4\">5.6.3.3 \uc778\ub3c4<\/li>\n<li class=\"toc-level-4\">5.6.3.4 \ub300\ud55c\ubbfc\uad6d<\/li>\n<li class=\"toc-level-4\">5.6.3.5 \ud638\uc8fc<\/li>\n<li class=\"toc-level-4\">5.6.3.6 \uae30\ud0c0 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-3\">5.6.4 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74\n<ul>\n<li class=\"toc-level-4\">5.6.4.1 GCC<\/li>\n<li class=\"toc-level-4\">5.6.4.2 \ub0a8\uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.6.4.3 \uae30\ud0c0 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-3\">5.6.5 \ub0a8\ubbf8\n<ul>\n<li class=\"toc-level-4\">5.6.5.1 \ube0c\ub77c\uc9c8<\/li>\n<li class=\"toc-level-4\">5.6.5.2 \uc544\ub974\ud5e8\ud2f0\ub098<\/li>\n<li class=\"toc-level-4\">5.6.5.3 \uae30\ud0c0 \ub0a8\ubbf8<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-5\">6. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">6.1 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4<\/li>\n<li class=\"toc-level-2\">6.2 \uc804\ub7b5\uc801 \uc6c0\uc9c1\uc784<\/li>\n<li class=\"toc-level-2\">6.3 \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d<\/li>\n<li class=\"toc-level-2\">6.4 \uae30\uc5c5 \ud504\ub85c\ud544 (\uae00\ub85c\ubc8c \uac1c\uc694, \uc2dc\uc7a5 \uac1c\uc694, \ud575\uc2ec \ubd80\ubb38, \uc7ac\ubb34 \uc815\ubcf4(\uc0ac\uc6a9 \uac00\ub2a5\ud55c \uacbd\uc6b0), \uc804\ub7b5 \uc815\ubcf4, \uc8fc\uc694 \uae30\uc5c5\uc758 \uc2dc\uc7a5 \uc21c\uc704\/\uc810\uc720\uc728, \uc81c\ud488 \ubc0f \uc11c\ube44\uc2a4, \ucd5c\uadfc \uac1c\ubc1c \ud3ec\ud568)\n<ul>\n<li class=\"toc-level-3\">6.4.1 \uc554\uc820(Amgen Inc.)<\/li>\n<li class=\"toc-level-3\">6.4.2 \uc7ac\uc988 \ud30c\ub9c8\uc288\ud2f0\uceec\uc2a4(Jazz Pharmaceuticals)<\/li>\n<li class=\"toc-level-3\">6.4.3 \ub178\ubc14\ud2f0\uc2a4(Novartis AG)<\/li>\n<li class=\"toc-level-3\">6.4.4 \ud654\uc774\uc790(Pfizer Inc.)<\/li>\n<li class=\"toc-level-3\">6.4.5 F. \ud638\ud504\ub9cc-\ub77c \ub85c\uc288(F. Hoffmann-La Roche Ltd)<\/li>\n<li class=\"toc-level-3\">6.4.6 \uc874\uc2a8\uc564\ub4dc\uc874\uc2a8 (\uc580\uc13c)<\/li>\n<li class=\"toc-level-3\">6.4.7 \uae38\ub9ac\uc5b4\ub4dc \uc0ac\uc774\uc5b8\uc2a4 (\uce74\uc774\ud2b8 \ud30c\ub9c8)<\/li>\n<li class=\"toc-level-3\">6.4.8 \uba54\ub2e5(Medac GmbH)<\/li>\n<li class=\"toc-level-3\">6.4.9 \ub2e4\ucf00\ub2e4 \uc81c\uc57d(Takeda Pharmaceutical Co.)<\/li>\n<li class=\"toc-level-3\">6.4.10 \uc624\ud1a0\ub7ec\uc2a4 \ud14c\ub77c\ud4e8\ud2f1\uc2a4(Autolus Therapeutics plc)<\/li>\n<li class=\"toc-level-3\">6.4.11 \ubca0\uc774\uc9c4(BeiGene Ltd.)<\/li>\n<li class=\"toc-level-3\">6.4.12 \uc138\ub974\ube44\uc5d0 \uadf8\ub8f9(Servier Group)<\/li>\n<li class=\"toc-level-3\">6.4.13 \uba38\ud06c(Merck &amp; Co. Inc.)<\/li>\n<li class=\"toc-level-3\">6.4.14 \uc560\ube0c\ube44(AbbVie Inc.)<\/li>\n<li class=\"toc-level-3\">6.4.15 \uc2e0\ub2e5\uc2a4 \ud30c\ub9c8\uc288\ud2f0\uceec\uc2a4(Syndax Pharmaceuticals)<\/li>\n<li class=\"toc-level-3\">6.4.16 \ubc14\uc774\ub85c\ub125\uc2dc\uc2a4 \ubc14\uc774\uc624\ud14c\ub77c\ud4e8\ud2f1\uc2a4(Vironexis Biotherapeutics).<\/li>\n<li class=\"toc-level-3\">6.4.17 \uc5b4\uc13c\ud2f0\uc9c0 \ud30c\ub9c8(Ascentage Pharma)<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-6\">7. \uc2dc\uc7a5 \uae30\ud68c \ubc0f \ubbf8\ub798 \uc804\ub9dd<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\uae09\uc131 \ub9bc\ud504\ubaa8\uad6c \ubc31\ud608\ubcd1 \uce58\ub8cc\uc81c \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc804\ub9dd (2026-2031)<\/p>\n<p>1. \uc2dc\uc7a5 \uac1c\uc694 \ubc0f \uc804\ub9dd<br \/>\n\uae09\uc131 \ub9bc\ud504\ubaa8\uad6c \ubc31\ud608\ubcd1(ALL) \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc740 2026\ub144 40\uc5b5 4\ucc9c\ub9cc \ub2ec\ub7ec \uaddc\ubaa8\uc5d0\uc11c 2031\ub144 55\uc5b5 3\ucc9c\ub9cc \ub2ec\ub7ec\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub418\uba70, \uc608\uce21 \uae30\uac04(2026-2031) \ub3d9\uc548 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR) 6.48%\ub97c \uae30\ub85d\ud560 \uc804\ub9dd\uc785\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uc131\uc7a5\uc740 \ud45c\uc801 \uce58\ub8cc\uc81c, \uba74\uc5ed \uce58\ub8cc\uc81c, \uc138\ud3ec \uae30\ubc18 \uc81c\ud488\uc758 \uc784\uc0c1\uc801 \uc131\uacf5\uc5d0 \ud798\uc785\uc5b4 \uacfc\uac70 \ub2e4\uc81c \ud654\ud559\uc694\ubc95\uc774 \uc9c0\ubc30\ud558\ub358 \uce58\ub8cc \ud504\ub85c\ud1a0\ucf5c\uc774 \uc7ac\uc815\uc758\ub418\uace0 \uc788\uae30 \ub54c\ubb38\uc785\ub2c8\ub2e4.<\/p>\n<p>\uc9c0\uc5ed\ubcc4\ub85c\ub294 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc774 2030\ub144\uae4c\uc9c0 9.80%\uc758 \uac00\uc7a5 \ube60\ub978 CAGR\uc744 \ubcf4\uc774\uba70 \ud655\uc7a5\ub420 \uac83\uc73c\ub85c \uc608\uc0c1\ub418\ub294\ub370, \uc774\ub294 \uc911\uad6d\uacfc \uc778\ub3c4\uc758 \ubcf4\ud5d8 \uc801\uc6a9 \ubc94\uc704 \ud655\ub300\uac00 \uc9c4\ub2e8 \ubc0f \uce58\ub8cc\ub7c9 \uc99d\uac00\ub85c \uc774\uc5b4\uc9c0\uace0 \uc788\uae30 \ub54c\ubb38\uc785\ub2c8\ub2e4. \ubd81\ubbf8 \uc9c0\uc5ed\uc740 2024\ub144 \ub9e4\ucd9c\uc758 37.6%\ub97c \ucc28\uc9c0\ud558\uba70 \uc120\ub450 \uc790\ub9ac\ub97c \uc720\uc9c0\ud558\uace0 \uc788\uc73c\uba70, \uc774\ub294 \ub192\uc740 \uc9c4\ub8cc \uc9c0\uce68 \uc900\uc218\uc728, \uc2e0\uc57d \ucd9c\uc2dc\uc758 \ube60\ub978 \uc811\uadfc\uc131, CAR-T \uce58\ub8cc\uc640 \uac19\uc740 \uace0\uac00 \uce58\ub8cc\ubc95\uc5d0 \ub300\ud55c \uc9c0\uc18d\uc801\uc778 \ubcf4\ud5d8 \uc801\uc6a9\uc5d0 \ud798\uc785\uc740 \ubc14\uac00 \ud07d\ub2c8\ub2e4. \ud30c\uc774\ud504\ub77c\uc778\uc758 \uac15\uc810\uc740 \ud544\ub77c\ub378\ud53c\uc544 \uc5fc\uc0c9\uccb4 \uc591\uc131 \uc9c8\ud658 \ubc0f KMT2A \uc7ac\ubc30\uc5f4 \uc544\ud615\uc744 \ub2e4\ub8e8\ub294 \uc57d\ubb3c\uc5d0\uc11c \uac00\uc7a5 \ub450\ub4dc\ub7ec\uc9c0\uba70, \ubbf8\uc138\uc794\uc874\uc9c8\ud658(MRD) \uac80\uc0ac\uc758 \uad11\ubc94\uc704\ud55c \uc0ac\uc6a9\uc740 \uce58\ub8cc \ubcc0\uacbd\uae4c\uc9c0\uc758 \uc2dc\uac04\uc744 \ub2e8\ucd95\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uadf8\ub7ec\ub098 \ub2e8\uc77c CAR-T \uce58\ub8cc \uacfc\uc815\uc774 \ud3c9\uade0 52\ub9cc 5\ucc9c \ub2ec\ub7ec\uc5d0 \ub2ec\ud558\ub294 \ub4f1 \uac00\uaca9 \uc555\ubc15\uc740 \uc5ec\uc804\ud788 \uad6c\uc870\uc801\uc778 \ub09c\uad00\uc73c\ub85c \uc791\uc6a9\ud558\uc5ec \uc911\uc18c\ub4dd \uad6d\uac00\uc5d0\uc11c\uc758 \uacf5\ud3c9\ud55c \uc811\uadfc\uc744 \uc5b4\ub835\uac8c \ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>2. \uc2dc\uc7a5 \uc131\uc7a5 \ub3d9\ub825<br \/>\n\uae09\uc131 \ub9bc\ud504\ubaa8\uad6c \ubc31\ud608\ubcd1 \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc758 \uc131\uc7a5\uc744 \uacac\uc778\ud558\ub294 \uc8fc\uc694 \uc694\uc778\ub4e4\uc740 \ub2e4\uc74c\uacfc \uac19\uc2b5\ub2c8\ub2e4.<br \/>\n*   \ub192\uc740 ALL \ubc1c\ubcd1\ub960 \ubc0f \uc18c\uc544\uc554 \uce58\ub8cc \ud504\ub85c\uadf8\ub7a8: \uc18c\uc544 ALL\uc758 \ub192\uc740 \uc804 \uc138\uacc4\uc801 \ubc1c\ubcd1\ub960\uc740 \uc2dc\uc7a5 \uc131\uc7a5\uc5d0 \uc9c0\uc18d\uc801\uc73c\ub85c \uae30\uc5ec\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. 2024\ub144 \ubbf8\uad6d\uc5d0\uc11c 6,550\uac74\uc758 \uc0c8\ub85c\uc6b4 ALL \uc0ac\ub840\uac00 \ubc1c\uc0dd\ud588\uc73c\uba70, ALL\uc740 \uc18c\uc544 \ubc31\ud608\ubcd1\uc758 80%\ub97c \ucc28\uc9c0\ud569\ub2c8\ub2e4. \uc18c\uc544\uc554 \uc804\ubb38 \ucee8\uc18c\uc2dc\uc5c4\ub4e4\uc740 \uc0dd\uc874\uc728\uc744 \ud5a5\uc0c1\uc2dc\ucf1c \uc654\uc73c\uba70, \ube14\ub9ac\ub098\ud22c\ubaa8\ub9d9(blinatumomab)\uc774 3\ub144 \ubb34\ubcd1 \uc0dd\uc874\uc728\uc744 87.9%\uc5d0\uc11c 96.0%\ub85c \ub04c\uc5b4\uc62c\ub9b0 Children\u2019s Oncology Group\uc758 3\uc0c1 \uc5f0\uad6c\uac00 \ub300\ud45c\uc801\uc778 \uc608\uc785\ub2c8\ub2e4. 2021\ub144 \uc804 \uc138\uacc4 \uc18c\uc544 ALL \uc720\ubcd1\ub960\uc740 168,879\uac74\uc73c\ub85c \uc9c0\ub09c 20\ub144\uac04 59.06% \uc99d\uac00\ud588\uc2b5\ub2c8\ub2e4. \uc774\ub7ec\ud55c \ud1b5\uacc4\ub294 \uc18c\uc544 \ud2b9\uc774\uc801 \uce58\ub8cc\ubc95 \ubc0f \uc6b0\uc218 \uc13c\ud130 \uc778\ud504\ub77c\uc5d0 \ub300\ud55c \uc9c0\uc18d\uc801\uc778 \ud22c\uc790\ub97c \ub4b7\ubc1b\uce68\ud558\uba70, \uc774\ub294 \uc758\uc57d\ud488 \ucc44\ud0dd \ubc0f \uc9c4\ub8cc \uc9c0\uce68\uc758 \uc218\ub834\uc744 \ucd09\uc9c4\ud569\ub2c8\ub2e4.<br \/>\n*   \ud655\ub300\ub418\ub294 R&#038;D \ubc0f \uc784\uc0c1 \uc2dc\ud5d8 \ud30c\uc774\ud504\ub77c\uc778: \ud65c\ubc1c\ud55c \uac1c\ubc1c \uc0dd\ud0dc\uacc4\ub294 \uce58\ub8cc \uc635\uc158\uc744 \uc7ac\ud3b8\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. 2024\ub144 7\uc6d4 UCART22\uc5d0 \ub300\ud55c \ud76c\uadc0 \uc18c\uc544 \uc9c8\ud658 \uc9c0\uc815\uc740 \ucc28\uc138\ub300 \ub3d9\uc885 \uc138\ud3ec \uce58\ub8cc\uc81c\uc5d0 \ub300\ud55c \uaddc\uc81c \ub2f9\uad6d\uc758 \uc5f4\uc758\ub97c \ubcf4\uc5ec\uc90d\ub2c8\ub2e4. \ub808\ubd80\ud3ec\ub974\uc9c0(Revuforj, revumenib)\ub294 2024\ub144 \ub9d0 KMT2A \uc7ac\ubc30\uc5f4 \ubc31\ud608\ubcd1\uc5d0\uc11c 63%\uc758 \ubc18\uc751\ub960\uc744 \ubcf4\uc774\uba70 \uba54\ub2cc(menin) \uc5b5\uc81c\uac00 \uc720\ud6a8\ud55c \uc804\ub7b5\uc784\uc744 \uc785\uc99d\ud588\uc2b5\ub2c8\ub2e4. \uc774\uc678\uc5d0\ub3c4 \uc774\uc911 \ud56d\uc6d0 \uad6c\uc870 \ubc0f \uae30\uc131\ud488(off-the-shelf) \ud50c\ub7ab\ud3fc\uc744 \ud3ec\ud568\ud558\ub294 CAR-T \uc5f0\uad6c\uac00 \uac15\ud654\ub418\uc5b4 \uc81c\uc870 \uc9c0\uc5f0\uc744 \uc904\uc774\uace0 \ud658\uc790 \uc801\uaca9\uc131\uc744 \ud655\ub300\ud558\uba70 \uae09\uc131 \ub9bc\ud504\ubaa8\uad6c \ubc31\ud608\ubcd1 \uce58\ub8cc\uc81c\uc758 \uaddc\ubaa8 \ud655\uc7a5\uc744 \uc9c0\uc6d0\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc6b0\ud638\uc801\uc778 \uc2e0\uc18d \uc2b9\uc778 \uacbd\ub85c: \uaddc\uc81c \ub2f9\uad6d\uc740 \uc601\ud5a5\ub825 \uc788\ub294 \uc2e0\uc57d\uc758 \uc0c1\uc5c5\ud654 \uc77c\uc815\uc744 \ub2e8\ucd95\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. 2024\ub144 FDA\uc758 \uc2e0\uc57d \uc2b9\uc778 \uc911 3\ubd84\uc758 2\uac00 \uc2e0\uc18d \uc2b9\uc778 \uacbd\ub85c\ub97c \ud65c\uc6a9\ud588\uc73c\uba70, \ud3ec\ub098\ud2f0\ub2d9(ponatinib)\uacfc \ud654\ud559\uc694\ubc95 \ubcd1\uc6a9\uc740 2024\ub144 3\uc6d4 \ud544\ub77c\ub378\ud53c\uc544 \uc5fc\uc0c9\uccb4 \uc591\uc131 \uc9c8\ud658\uc758 1\ucc28 \uce58\ub8cc\uc81c\ub85c \uac00\uc18d \uc2b9\uc778\uc744 \ubc1b\uc558\uc2b5\ub2c8\ub2e4. \uc720\ub7fd\uacfc \uc77c\ubcf8\uc5d0\uc11c\ub3c4 \uc720\uc0ac\ud55c \uba54\ucee4\ub2c8\uc998\uc774 \ud655\uc0b0\ub418\uc5b4 \uc804 \uc138\uacc4 \ucd9c\uc2dc \uc21c\uc11c\ub97c \uc815\uad50\ud654\ud558\uace0 \uc81c\uc870\uc5c5\uccb4\uc758 \uc608\uce21 \uc2e0\ub8b0\ub3c4\ub97c \ub192\uc774\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc561\uccb4 \uc0dd\uac80 \ubc0f MRD \uac80\uc0ac\uc758 \uad11\ubc94\uc704\ud55c \uc0ac\uc6a9: 0.01%\uc758 \ubbfc\uac10\ub3c4\ub97c \uac00\uc9c4 CTDNA \uae30\ubc18 \ubd84\uc11d\ubc95\uc740 \uc870\uae30 \uce58\ub8cc \uac15\ud654\ub97c \uac00\ub2a5\ud558\uac8c \ud569\ub2c8\ub2e4. \ube14\ub9ac\ub098\ud22c\ubaa8\ub9d9\uc744 \ud22c\uc5ec\ubc1b\uc740 \uc131\uc778 MRD \uc74c\uc131 B\uc138\ud3ec \uc804\uad6c\uccb4 \ud658\uc790\ub294 3\ub144 \uc804\uccb4\uc0dd\uc874\uc728\uc774 50% \uc774\uc0c1\uc73c\ub85c \ub098\ud0c0\ub0ac\uc2b5\ub2c8\ub2e4. \uc774\ub7ec\ud55c MRD \uac80\uc0ac\uc758 \ud65c\uc6a9\uc740 \uce58\ub8cc \ubc18\uc751\uc744 \uc870\uae30\uc5d0 \ud3c9\uac00\ud558\uace0, \uc794\uc874 \uc9c8\ud658\uc744 \uc815\ud655\ud558\uac8c \ud30c\uc545\ud558\uc5ec \ub9de\ucda4\ud615 \uce58\ub8cc \uc804\ub7b5\uc744 \uc218\ub9bd\ud558\ub294 \ub370 \ud544\uc218\uc801\uc778 \uc5ed\ud560\uc744 \ud569\ub2c8\ub2e4. \ud2b9\ud788, \uc561\uccb4 \uc0dd\uac80\uc740 \ube44\uce68\uc2b5\uc801 \ubc29\uc2dd\uc73c\ub85c \uc885\uc591\uc758 \uc720\uc804\uc801 \ubcc0\ud654\ub97c \ubaa8\ub2c8\ud130\ub9c1\ud558\uace0 \uce58\ub8cc \uc800\ud56d\uc131\uc744 \uc608\uce21\ud558\ub294 \ub370 \uae30\uc5ec\ud558\uba70, \uc774\ub294 \ud658\uc790 \uad00\ub9ac\uc758 \ud6a8\uc728\uc131\uc744 \ud06c\uac8c \ud5a5\uc0c1\uc2dc\ud0b5\ub2c8\ub2e4.<\/p>\n<p>*   \uc784\uc0c1 \uc2dc\ud5d8\uc758 \ubc1c\uc804: \uc784\uc0c1 \uc2dc\ud5d8 \uc124\uacc4\uc758 \ud601\uc2e0\uc740 \ud658\uc790 \ubaa8\uc9d1\uc744 \uac00\uc18d\ud654\ud558\uace0 \uc2e0\uc57d \uac1c\ubc1c\uc758 \ud6a8\uc728\uc131\uc744 \ub192\uc774\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc801\uc751\ud615 \uc784\uc0c1 \uc2dc\ud5d8(adaptive trial designs)\uacfc \uc2e4\uc138\uacc4 \ub370\uc774\ud130(real-world data, RWD)\uc758 \ud1b5\ud569\uc740 \uce58\ub8cc\ubc95\uc758 \ud6a8\uacfc\ub97c \ubcf4\ub2e4 \uc815\ud655\ud558\uac8c \ud3c9\uac00\ud558\uace0, \ud2b9\uc815 \ud658\uc790\uad70\uc5d0 \ub300\ud55c \ub9de\ucda4\ud615 \uce58\ub8cc\ubc95 \uac1c\ubc1c\uc744 \ucd09\uc9c4\ud569\ub2c8\ub2e4. \ub610\ud55c, \ubd84\uc790 \ud504\ub85c\ud30c\uc77c\ub9c1\uc744 \uae30\ubc18\uc73c\ub85c \ud55c \uc815\ubc00 \uc758\ud559 \uc811\uadfc \ubc29\uc2dd\uc740 \uc784\uc0c1 \uc2dc\ud5d8\uc758 \uc131\uacf5\ub960\uc744 \ub192\uc774\ub294 \ub370 \uae30\uc5ec\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc774\ub7ec\ud55c \uc694\uc778\ub4e4\uc740 \uae09\uc131 \ub9bc\ud504\ubaa8\uad6c \ubc31\ud608\ubcd1 \uce58\ub8cc \uc2dc\uc7a5\uc758 \uc131\uc7a5\uc744 \uacac\uc778\ud558\uba70, \ud658\uc790\ub4e4\uc5d0\uac8c \ub354 \ub098\uc740 \uce58\ub8cc \uc635\uc158\uacfc \ud76c\ub9dd\uc744 \uc81c\uacf5\ud560 \uac83\uc73c\ub85c \uae30\ub300\ub429\ub2c8\ub2e4.<\/p>\n<p>\ubcf8 \ubcf4\uace0\uc11c\ub294 \uae09\uc131 \ub9bc\ud504\uad6c\uc131 \ubc31\ud608\ubcd1(ALL) \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc5d0 \ub300\ud55c \ud3ec\uad04\uc801\uc778 \ubd84\uc11d\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4. \uc774 \uc2dc\uc7a5\uc740 \uc804 \uc138\uacc4\uc801\uc73c\ub85c \uc18c\uc544(0-18\uc138), \uc131\uc778(19-64\uc138), \ub178\uc778(65\uc138 \uc774\uc0c1) \ud658\uc790\uad70\uc5d0\uc11c \ubc1c\uc0dd\ud558\ub294 B-\uc138\ud3ec, T-\uc138\ud3ec \ub610\ub294 \ud544\ub77c\ub378\ud53c\uc544 \uc5fc\uc0c9\uccb4 \uc591\uc131 ALL \uc9c4\ub2e8\uc744 \ubc1b\uc740 \ud658\uc790\uc5d0\uac8c \uce58\ub8cc \ub610\ub294 \uc644\ud654 \ubaa9\uc801\uc73c\ub85c \ud22c\uc5ec\ub418\ub294 \ubaa8\ub4e0 \ucc98\ubc29 \uc758\uc57d\ud488 \ubc0f \uc138\ud3ec \uae30\ubc18 \uc2dc\uc220\uc744 \ud3ec\ud568\ud569\ub2c8\ub2e4. \ud2b9\ud788 \uc815\ub9e5 \ub610\ub294 \uacbd\uad6c \ud22c\uc5ec \uc81c\ud615\ubfd0\ub9cc \uc544\ub2c8\ub77c CAR-T \uc138\ud3ec \uce58\ub8cc, \uc774\uc911 \ud2b9\uc774\uc131 \ud56d\uccb4, \ub3d9\uc885 \uc904\uae30\uc138\ud3ec \uc774\uc2dd\uacfc \uac19\uc740 \ucca8\ub2e8 \uce58\ub8cc\ubc95\uc774 \uc2dc\uc7a5 \ubc94\uc704\uc5d0 \ud3ec\ud568\ub418\uba70, \uc21c\uc218 \uc9c4\ub2e8 \ud0a4\ud2b8, \ubcf4\uc870 \uc694\ubc95\uc81c(\uc608: \ud56d\uad6c\ud1a0\uc81c, \uc131\uc7a5 \uc778\uc790), \uc784\uc0c1 \uc2dc\ud5d8 \ub2e8\uacc4\uc758 \ubd84\uc790\ub294 \uc81c\uc678\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uc131\uc7a5\uc758 \uc8fc\uc694 \ub3d9\uc778\uc73c\ub85c\ub294 \uae09\uc131 \ub9bc\ud504\uad6c\uc131 \ubc31\ud608\ubcd1\uc758 \ub192\uc740 \uc720\ubcd1\ub960\uacfc \uc18c\uc544\uc554 \uce58\ub8cc \ud504\ub85c\uadf8\ub7a8\uc758 \ubc1c\uc804, \uc5f0\uad6c \uac1c\ubc1c \uc774\ub2c8\uc154\ud2f0\ube0c \uc99d\uac00 \ubc0f \uc784\uc0c1 \uc2dc\ud5d8, \ud30c\uc774\ud504\ub77c\uc778 \uc57d\ubb3c\uc758 \ud655\uc7a5, \uac00\uc18d \uc2b9\uc778\uacfc \uac19\uc740 \uc6b0\ud638\uc801\uc778 \uaddc\uc81c \uc815\ucc45, \uc561\uccb4 \uc0dd\uac80 \ubc0f \ubbf8\uc138 \uc794\uc874 \uc9c8\ud658(MRD) \uac80\uc0ac\uc758 \uc801\uc6a9 \ud655\ub300, \ud45c\uc801 \uce58\ub8cc\ubc95\uc758 \uc9c0\uc18d\uc801\uc778 \ubc1c\uc804, \uadf8\ub9ac\uace0 \uc0c1\uc5c5\uc801 \ud655\uc7a5\uc131\uacfc \ud658\uc790 \uc801\uaca9\uc131\uc744 \uac00\uc18d\ud654\ud558\ub294 \uae30\uc131\ud488 \ub3d9\uc885 CAR-T \ud50c\ub7ab\ud3fc\uc73c\ub85c\uc758 \uc804\ud658 \ub4f1\uc774 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\ubc18\uba74, \ub192\uc740 \uce58\ub8cc \ube44\uc6a9 \ubc0f \ubcf4\ud5d8 \uc0c1\ud658 \ubb38\uc81c, \ubd80\uc791\uc6a9 \uc704\ud5d8 \ubc0f \uc7ac\ubc1c\/\uce58\ub8cc \uc800\ud56d\uc131, \uc758\ub8cc \uc811\uadfc\uc131\uc758 \ubd88\uade0\ud615 \ubc0f \uc2e0\uaddc \uce58\ub8cc\ubc95\uc758 \ubd88\ud655\uc2e4\ud55c \uc7a5\uae30 \uacb0\uacfc, \uadf8\ub9ac\uace0 \uc81c\ud55c\uc801\uc778 \ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130 \uc81c\uc870 \uc5ed\ub7c9\uc73c\ub85c \uc778\ud55c \uc0dd\uc0b0 \uc9c0\uc5f0 \ubc0f \uacf5\uae09 \uc81c\uc57d\uc740 \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uc800\ud574\ud558\ub294 \uc8fc\uc694 \uc694\uc778\uc73c\ub85c \uc791\uc6a9\ud569\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5\uc740 \uc138\ud3ec \uc720\ud615(B-\uc138\ud3ec \uc804\uad6c\uccb4 ALL, T-\uc138\ud3ec ALL, \ud544\ub77c\ub378\ud53c\uc544 \uc5fc\uc0c9\uccb4), \uce58\ub8cc\ubc95(\ud654\ud559\uc694\ubc95, \ud45c\uc801 \uce58\ub8cc\ubc95, \ubc29\uc0ac\uc120 \uce58\ub8cc, \uc904\uae30\uc138\ud3ec \uc774\uc2dd, CAR-T\/\uc138\ud3ec \uce58\ub8cc), \uc5f0\ub839\ub300(\uc18c\uc544, \uc131\uc778, \ub178\uc778), \uce58\ub8cc \ub2e8\uacc4(1\ucc28, 2\ucc28, \uc7ac\ubc1c\/\ubd88\uc751\uc131), \ud22c\uc5ec \uacbd\ub85c(\uc815\ub9e5, \uacbd\uad6c) \ubc0f \ubd81\ubbf8, \uc720\ub7fd, \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591, \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74, \ub0a8\ubbf8\ub97c \ud3ec\ud568\ud55c \uc9c0\uc5ed\ubcc4\ub85c \uc138\ubd84\ud654\ub418\uc5b4 \ubd84\uc11d\ub429\ub2c8\ub2e4.<\/p>\n<p>\ubcf4\uace0\uc11c\uc5d0 \ub530\ub974\uba74, \uae09\uc131 \ub9bc\ud504\uad6c\uc131 \ubc31\ud608\ubcd1 \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc740 2026\ub144 40\uc5b5 4\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0\uc11c 2031\ub144\uae4c\uc9c0 55\uc5b5 3\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0 \uc774\ub97c \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc740 9.57%\uc758 \uac00\uc7a5 \ube60\ub978 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960\uc744 \ubcf4\uc77c \uac83\uc73c\ub85c \uc608\uc0c1\ub418\uba70, \uce58\ub8cc\ubc95 \uc911\uc5d0\uc11c\ub294 \ud45c\uc801 \uce58\ub8cc\ubc95\uc774 8.25%\uc758 \uac00\uc7a5 \ub192\uc740 \uc131\uc7a5\ub960\uc744 \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc608\uce21\ub429\ub2c8\ub2e4. \ud2b9\ud788 \uc18c\uc544 \ud658\uc790 \uc218\uc694\ub294 2025\ub144 \ub9e4\ucd9c\uc758 63.25%\ub97c \ucc28\uc9c0\ud558\uba70 \uc2dc\uc7a5\uc758 \uc8fc\uc694 \ub3d9\ub825\uc784\uc744 \ubcf4\uc5ec\uc90d\ub2c8\ub2e4. \uacbd\uad6c \ud22c\uc5ec \uc81c\ud615 \ub610\ud55c 7.14%\uc758 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960\ub85c \uc99d\uac00\ud558\uba70 \ud3b8\uc758\uc131\uacfc \uc21c\uc751\ub3c4 \uac1c\uc120\uc5d0 \uae30\uc5ec\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uadf8\ub7ec\ub098 CAR-T \uc8fc\uc785 \ube44\uc6a9\uc774 525,000\ub2ec\ub7ec\uc5d0 \ub2ec\ud558\ub294 \ub4f1 \ub192\uc740 \uce58\ub8cc \ube44\uc6a9\uc740 \uc2e0\uaddc \uce58\ub8cc\ubc95\uc758 \uad11\ubc94\uc704\ud55c \ucc44\ud0dd\uc5d0 \uac00\uc7a5 \ud070 \uc7a5\uc560\ubb3c\ub85c \ub0a8\uc544\uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\ubcf8 \ubcf4\uace0\uc11c\ub294 \uc18c\uc544 \ud608\uc561\ud559\uc790, \uc131\uc778 \uc885\uc591\ud559\uc790, \ubcd1\uc6d0 \uc57d\uc0ac \ub4f1\uacfc\uc758 \uc2ec\uce35\uc801\uc778 1\ucc28 \uc5f0\uad6c\uc640 GLOBOCAN, CDC SEER \ub4f1\uc758 \uacf5\uac1c \uc5ed\ud559 \ub370\uc774\ud130\ub97c \ud65c\uc6a9\ud55c 2\ucc28 \uc5f0\uad6c\ub97c \uacb0\ud569\ud55c \uacac\uace0\ud55c \ubc29\ubc95\ub860\uc744 \uae30\ubc18\uc73c\ub85c \ud569\ub2c8\ub2e4. \uc2dc\uc7a5 \uaddc\ubaa8 \uc0b0\uc815 \ubc0f \uc608\uce21\uc740 \uad6d\uac00\ubcc4 ALL \ubc1c\uc0dd\ub960, \uc18c\uc544-\uc131\uc778 \ube44\uc728, \ud45c\uc801 \ub610\ub294 \uc138\ud3ec \uce58\ub8cc \uc801\uaca9 \ud658\uc790 \ube44\uc728, \ud3c9\uade0 \uce58\ub8cc \uae30\uac04, \ube0c\ub79c\ub4dc \ub300 \uc81c\ub124\ub9ad \uc57d\uac00 \ubcc0\ub3d9, \uaddc\uc81c \uc2b9\uc778 \uc8fc\uae30 \ub4f1 \ud575\uc2ec \uc785\ub825\uac12\uc744 \ud65c\uc6a9\ud558\uc5ec \uc774\ub8e8\uc5b4\uc9c0\uba70, \ub9e4\ub144 \uc5c5\ub370\uc774\ud2b8\ub429\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uba85\ud655\ud55c \ubc94\uc704 \uc124\uc815\uacfc \uc5c4\uaca9\ud55c \ubcc0\uc218 \uc120\ud0dd\uc740 \ubcf4\uace0\uc11c\uc758 \uc2e0\ub8b0\uc131\uc744 \ub192\uc785\ub2c8\ub2e4.<\/p>\n<p>\uacbd\uc7c1 \ud658\uacbd \ubd84\uc11d\uc740 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4, \uc8fc\uc694 \uae30\uc5c5\uc758 \uc804\ub7b5\uc801 \uc6c0\uc9c1\uc784, \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d \ubc0f Amgen Inc., Jazz Pharmaceuticals, Novartis AG, Pfizer Inc., F. Hoffmann-La Roche Ltd, Johnson &#038; Johnson (Janssen), Gilead Sciences (Kite Pharma) \ub4f1 \uc8fc\uc694 \uae30\uc5c5\ub4e4\uc758 \uc0c1\uc138 \ud504\ub85c\ud544\uc744 \ud3ec\ud568\ud569\ub2c8\ub2e4.<\/p>\n<p>\uacb0\ub860\uc801\uc73c\ub85c, \ubcf8 \ubcf4\uace0\uc11c\ub294 \uae09\uc131 \ub9bc\ud504\uad6c\uc131 \ubc31\ud608\ubcd1 \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc758 \ud604\uc7ac\uc640 \ubbf8\ub798\ub97c \uc2ec\uce35\uc801\uc73c\ub85c \uc870\uba85\ud558\uba70, \ubbf8\ucda9\uc871 \uc218\uc694 \ud3c9\uac00\ub97c \ud1b5\ud574 \uc2dc\uc7a5 \uae30\ud68c\uc640 \ubbf8\ub798 \uc804\ub9dd\uc744 \uc81c\uc2dc\ud568\uc73c\ub85c\uc368 \uc758\uc0ac \uacb0\uc815\uad8c\uc790\uc5d0\uac8c \uc2e0\ub8b0\ud560 \uc218 \uc788\ub294 \uc815\ubcf4\ub97c \uc81c\uacf5\ud569\ub2c8\ub2e4.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-54839","post","type-post","status-publish","format-standard","hentry","category-market-reports"],"_links":{"self":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/54839"}],"collection":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/comments?post=54839"}],"version-history":[{"count":0,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/54839\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/media?parent=54839"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/categories?post=54839"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/tags?post=54839"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}